South & Central America Blood Plasma Derivatives Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)
The South & Central America blood plasma derivatives market was valued at US$ 1,864.04 million in 2022 and is projected to reach US$ 3,067.15 million by 2028; it is expected to grow at a CAGR of 8.7% from 2022 to 2028.
Increasing Usage of Immunoglobulin G in Multiple Treatments is Driving the South & Central America Blood Plasma Derivatives Market
Immunoglobulin G (IgG) therapies are highly used to treat primary immune deficiency cause by the genetics. The demand for IgG has been increasing steadily for the last few years due to the increasing awareness of IgG therapy. The growth is also accounted for its new therapy for its newly identified indication. Based on controlled trials done by Network Meta Analysis (NMA), IgG therapy has been approved for the treatment of Guillain-Barrй syndrome (GBS), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Multifocal Motor Neuropathy (MMN), and dermatomyositis. The Immunoglobulin G (IgG) therapies is also effective for the treatment of myasthenia gravis exacerbations and stiff-person syndrome. In addition, it provides convincing efficacy in autoimmune disorders like epilepsy, neuromyelitis, and autoimmune encephalitis.
A large proportion of IgG is used in specialties outside of immunology, such as oncology, neurology, hematology, and rheumatology. Compared to all, neurology is the fastest-growing specialty in the global market. The growth of the Immunoglobulin G market is attributed due to its approved for on-label use for chronic inflammatory demyelinating polyneuropathy (CIDP) followed by its off-label use in secondary immune deficiencies caused by lymphoma, myeloma, and leukemia and the certain immunosuppressive therapies esp. B-cell targeting therapies. Thus, the wide range of IgG usage in multiple treatments for on-label and off-label prescription will continue to expand and drive IgG demand across the global market in the coming years.
South & Central America Blood Plasma Derivatives Market Overview
The South & Central America blood plasma derivatives market has been segmented into Brazil, Argentina, and the Rest of South & Central America. The region has a high prevalence of hemophilia, von Willebrand disease, and other bleeding disorders, increasing the adoption of plasma derivatives products for treatment. For instance, according to the World Federation of Hemophilia (WFH) Annual Global Survey 2021, Brazil and Argentina have a significantly high number of active hemophilia, von Willebrand disease, and other bleeding disorders cases. In 2021, Brazil had 13,337 people with Hemophilia, 10,231 with von Willebrand disease, and 3,959 with other bleeding disorders. At the same time, Argentina had 2,843 people with Hemophilia, 399 people with von Willebrand disease, and 11 people with other bleeding disorders.
Furthermore, according to the CDC (U.S. Department of Health & Human Services), countries such as Brazil have a recommendation for travelers who are allergic to a vaccine component or who are younger than six months should receive a single dose of immune globulin, which provides effective protection for up to 2 months depending on the dosage given. Additionally, various global plasma derivative manufacturers are expanding their business into South & Central America, boosting market growth. For instance, in November 2019, Grifols announced the start of production at its new blood-collection systems plant in Campo Largo, Brazil. The production line is fulfilling local customer orders in the region. It has an annual capacity of more than 10 million blood collection bags, and the more than 5,500-square-meter plant is expected to increase output to serve the broader Latin American region gradually.
Exhibit: South & Central America Blood plasma derivatives Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Blood plasma derivatives Market Segmentation
The South & Central America blood plasma derivatives market is segmented into type, application, end user, and country.
The South & Central America blood plasma derivatives market, by type, is segmented into albumin, factor VIII, factor IX, immunoglobulin, hyperimmune globulin, and others. The immunoglobulins segment held a larger market share in 2022.
Based on application, the South & Central America blood plasma derivatives market is divided into hemophilia, hypogammaglobulinemia, immunodeficiency diseases, von Willebrand disease, and other applications. The immunodeficiency diseases applications segment held the largest share of the market in 2022.
The blood plasma derivatives market, by end user, is segmented into hospitals, diagnostic laboratories, clinics, and other end users. The hospitals segment held the largest share of the market in 2022.
Based on country, the South & Central America blood plasma derivatives market is segmented into Brazil, Argentina, and the Rest of South & Central America. Saudi Arabia dominated the market in 2022.
Grifols SA; Octapharma AG; Monobind Inc.; CSL Behring LLC; LFB SA; Kedrion SpA; and Takeda Pharmaceutical Co Ltd are the leading companies operating in the South & Central America blood plasma derivatives market.
Increasing Usage of Immunoglobulin G in Multiple Treatments is Driving the South & Central America Blood Plasma Derivatives Market
Immunoglobulin G (IgG) therapies are highly used to treat primary immune deficiency cause by the genetics. The demand for IgG has been increasing steadily for the last few years due to the increasing awareness of IgG therapy. The growth is also accounted for its new therapy for its newly identified indication. Based on controlled trials done by Network Meta Analysis (NMA), IgG therapy has been approved for the treatment of Guillain-Barrй syndrome (GBS), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Multifocal Motor Neuropathy (MMN), and dermatomyositis. The Immunoglobulin G (IgG) therapies is also effective for the treatment of myasthenia gravis exacerbations and stiff-person syndrome. In addition, it provides convincing efficacy in autoimmune disorders like epilepsy, neuromyelitis, and autoimmune encephalitis.
A large proportion of IgG is used in specialties outside of immunology, such as oncology, neurology, hematology, and rheumatology. Compared to all, neurology is the fastest-growing specialty in the global market. The growth of the Immunoglobulin G market is attributed due to its approved for on-label use for chronic inflammatory demyelinating polyneuropathy (CIDP) followed by its off-label use in secondary immune deficiencies caused by lymphoma, myeloma, and leukemia and the certain immunosuppressive therapies esp. B-cell targeting therapies. Thus, the wide range of IgG usage in multiple treatments for on-label and off-label prescription will continue to expand and drive IgG demand across the global market in the coming years.
South & Central America Blood Plasma Derivatives Market Overview
The South & Central America blood plasma derivatives market has been segmented into Brazil, Argentina, and the Rest of South & Central America. The region has a high prevalence of hemophilia, von Willebrand disease, and other bleeding disorders, increasing the adoption of plasma derivatives products for treatment. For instance, according to the World Federation of Hemophilia (WFH) Annual Global Survey 2021, Brazil and Argentina have a significantly high number of active hemophilia, von Willebrand disease, and other bleeding disorders cases. In 2021, Brazil had 13,337 people with Hemophilia, 10,231 with von Willebrand disease, and 3,959 with other bleeding disorders. At the same time, Argentina had 2,843 people with Hemophilia, 399 people with von Willebrand disease, and 11 people with other bleeding disorders.
Furthermore, according to the CDC (U.S. Department of Health & Human Services), countries such as Brazil have a recommendation for travelers who are allergic to a vaccine component or who are younger than six months should receive a single dose of immune globulin, which provides effective protection for up to 2 months depending on the dosage given. Additionally, various global plasma derivative manufacturers are expanding their business into South & Central America, boosting market growth. For instance, in November 2019, Grifols announced the start of production at its new blood-collection systems plant in Campo Largo, Brazil. The production line is fulfilling local customer orders in the region. It has an annual capacity of more than 10 million blood collection bags, and the more than 5,500-square-meter plant is expected to increase output to serve the broader Latin American region gradually.
Exhibit: South & Central America Blood plasma derivatives Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Blood plasma derivatives Market Segmentation
The South & Central America blood plasma derivatives market is segmented into type, application, end user, and country.
The South & Central America blood plasma derivatives market, by type, is segmented into albumin, factor VIII, factor IX, immunoglobulin, hyperimmune globulin, and others. The immunoglobulins segment held a larger market share in 2022.
Based on application, the South & Central America blood plasma derivatives market is divided into hemophilia, hypogammaglobulinemia, immunodeficiency diseases, von Willebrand disease, and other applications. The immunodeficiency diseases applications segment held the largest share of the market in 2022.
The blood plasma derivatives market, by end user, is segmented into hospitals, diagnostic laboratories, clinics, and other end users. The hospitals segment held the largest share of the market in 2022.
Based on country, the South & Central America blood plasma derivatives market is segmented into Brazil, Argentina, and the Rest of South & Central America. Saudi Arabia dominated the market in 2022.
Grifols SA; Octapharma AG; Monobind Inc.; CSL Behring LLC; LFB SA; Kedrion SpA; and Takeda Pharmaceutical Co Ltd are the leading companies operating in the South & Central America blood plasma derivatives market.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Blood Plasma Derivatives Market – by Type
1.3.2 South & Central America Blood Plasma Derivatives Market – by Application
1.3.3 South & Central America Blood Plasma Derivatives Market – by End User
1.3.4 South & Central America Blood Plasma Derivatives Market – by Country
2. SOUTH & CENTRAL AMERICA BLOOD PLASMA DERIVATIVES MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SOUTH & CENTRAL AMERICA BLOOD PLASMA DERIVATIVES MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 South & Central America PEST Analysis
4.3 Expert’s Opinion
5. SOUTH & CENTRAL AMERICA BLOOD PLASMA DERIVATIVES MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increase in Prevalence of Blood Disorders
5.1.2 Rise in Geriatric Population
5.2 Market Restraints
5.2.1 Complicated Reimbursement Policies
5.3 Market Opportunities
5.3.1 Incorporation of Platelet-Rich Plasma in Regenerative Medicine
5.4 Future Trends
5.4.1 Increasing Usage of Immunoglobulin G in Multiple Treatments
5.5 Impact Analysis
6. BLOOD PLASMA DERIVATIVES MARKET – SOUTH & CENTRAL AMERICA ANALYSIS
6.1 South & Central America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7. SOUTH & CENTRAL AMERICA BLOOD PLASMA DERIVATIVES MARKET – REVENUE AND FORECAST TO 2028 – BY TYPE
7.1 Overview
7.2 South & Central America Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)
7.3 Albumin
7.3.1 Overview
7.3.2 Albumin: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Factor VIII
7.4.1 Overview
7.4.2 Factor VIII: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Factor IX
7.5.1 Overview
7.5.2 Factor IX: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Immunoglobulin
7.6.1 Overview
7.6.2 Immunoglobulin: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.3 IgG
7.6.3.1 Overview
7.6.3.2 IgG: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.4 IgM
7.6.4.1 Overview
7.6.4.2 IgM: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.5 IgA
7.6.5.1 Overview
7.6.5.2 IgA: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.6 IgD
7.6.6.1 Overview
7.6.6.2 IgD: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.7 IgE
7.6.7.1 Overview
7.6.7.2 IgE: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Hyperimmune Globulin
7.7.1 Overview
7.7.2 Hyperimmune Globulin: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8. SOUTH & CENTRAL AMERICA BLOOD PLASMA DERIVATIVES MARKET ANALYSIS AND FORECASTS TO 2028 – BY APPLICATION
8.1 Overview
8.2 South & Central America Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)
8.3 Hemophilia
8.3.1 Overview
8.3.2 Hemophilia: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Hypogammaglobulinemia
8.4.1 Overview
8.4.2 Hypogammaglobulinemia: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Immunodeficiency Diseases
8.5.1 Overview
8.5.2 Immunodeficiency Diseases: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Von Willebrand Disease
8.6.1 Overview
8.6.2 Von Willebrand Disease: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Other Applications
8.7.1 Overview
8.7.2 Other Applications: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9. SOUTH & CENTRAL AMERICA BLOOD PLASMA DERIVATIVES MARKET – REVENUE AND FORECAST TO 2028 – BY END USER
9.1 Overview
9.2 South & Central America Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Other End Users
9.5.1 Overview
9.5.2 Other End Users: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10. SOUTH & CENTRAL AMERICA BLOOD PLASMA DERIVATIVES MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 Overview
10.1.1 South & Central America: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.1 South & Central America: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.2 South & Central America: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.3 South & Central America Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.3.1 Brazil: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.1.1 Overview
10.1.3.1.2 Brazil: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.1.3 Brazil: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.3.1.3.1 Brazil: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.3.1.4 Brazil: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.3.1.5 Brazil Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.3.2 Argentina: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.2.1 Overview
10.1.3.2.2 Argentina: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.2.3 Argentina: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.3.2.3.1 Argentina: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.3.2.4 Argentina: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.3.2.5 Argentina Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.3.3 Rest of South & Central America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.3.1 Overview
10.1.3.3.2 Rest of South & Central America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.3.3 Rest of South & Central America: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.3.3.3.1 Rest of Middle East: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.3.3.4 Rest of South & Central America: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.3.3.5 Rest of South & Central America Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the Blood Plasma Derivatives Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Grifols SA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Octapharma AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Monobind Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Takeda Pharmaceutical Co Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 CSL Behring LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 LFB SA
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Kedrion SpA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Blood Plasma Derivatives Market – by Type
1.3.2 South & Central America Blood Plasma Derivatives Market – by Application
1.3.3 South & Central America Blood Plasma Derivatives Market – by End User
1.3.4 South & Central America Blood Plasma Derivatives Market – by Country
2. SOUTH & CENTRAL AMERICA BLOOD PLASMA DERIVATIVES MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SOUTH & CENTRAL AMERICA BLOOD PLASMA DERIVATIVES MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 South & Central America PEST Analysis
4.3 Expert’s Opinion
5. SOUTH & CENTRAL AMERICA BLOOD PLASMA DERIVATIVES MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increase in Prevalence of Blood Disorders
5.1.2 Rise in Geriatric Population
5.2 Market Restraints
5.2.1 Complicated Reimbursement Policies
5.3 Market Opportunities
5.3.1 Incorporation of Platelet-Rich Plasma in Regenerative Medicine
5.4 Future Trends
5.4.1 Increasing Usage of Immunoglobulin G in Multiple Treatments
5.5 Impact Analysis
6. BLOOD PLASMA DERIVATIVES MARKET – SOUTH & CENTRAL AMERICA ANALYSIS
6.1 South & Central America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7. SOUTH & CENTRAL AMERICA BLOOD PLASMA DERIVATIVES MARKET – REVENUE AND FORECAST TO 2028 – BY TYPE
7.1 Overview
7.2 South & Central America Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)
7.3 Albumin
7.3.1 Overview
7.3.2 Albumin: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Factor VIII
7.4.1 Overview
7.4.2 Factor VIII: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Factor IX
7.5.1 Overview
7.5.2 Factor IX: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Immunoglobulin
7.6.1 Overview
7.6.2 Immunoglobulin: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.3 IgG
7.6.3.1 Overview
7.6.3.2 IgG: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.4 IgM
7.6.4.1 Overview
7.6.4.2 IgM: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.5 IgA
7.6.5.1 Overview
7.6.5.2 IgA: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.6 IgD
7.6.6.1 Overview
7.6.6.2 IgD: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.7 IgE
7.6.7.1 Overview
7.6.7.2 IgE: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Hyperimmune Globulin
7.7.1 Overview
7.7.2 Hyperimmune Globulin: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8. SOUTH & CENTRAL AMERICA BLOOD PLASMA DERIVATIVES MARKET ANALYSIS AND FORECASTS TO 2028 – BY APPLICATION
8.1 Overview
8.2 South & Central America Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)
8.3 Hemophilia
8.3.1 Overview
8.3.2 Hemophilia: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Hypogammaglobulinemia
8.4.1 Overview
8.4.2 Hypogammaglobulinemia: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Immunodeficiency Diseases
8.5.1 Overview
8.5.2 Immunodeficiency Diseases: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Von Willebrand Disease
8.6.1 Overview
8.6.2 Von Willebrand Disease: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Other Applications
8.7.1 Overview
8.7.2 Other Applications: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9. SOUTH & CENTRAL AMERICA BLOOD PLASMA DERIVATIVES MARKET – REVENUE AND FORECAST TO 2028 – BY END USER
9.1 Overview
9.2 South & Central America Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Other End Users
9.5.1 Overview
9.5.2 Other End Users: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10. SOUTH & CENTRAL AMERICA BLOOD PLASMA DERIVATIVES MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 Overview
10.1.1 South & Central America: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.1 South & Central America: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.2 South & Central America: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.3 South & Central America Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.3.1 Brazil: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.1.1 Overview
10.1.3.1.2 Brazil: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.1.3 Brazil: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.3.1.3.1 Brazil: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.3.1.4 Brazil: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.3.1.5 Brazil Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.3.2 Argentina: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.2.1 Overview
10.1.3.2.2 Argentina: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.2.3 Argentina: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.3.2.3.1 Argentina: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.3.2.4 Argentina: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.3.2.5 Argentina Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.3.3 Rest of South & Central America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.3.1 Overview
10.1.3.3.2 Rest of South & Central America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.3.3 Rest of South & Central America: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.3.3.3.1 Rest of Middle East: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.3.3.4 Rest of South & Central America: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.3.3.5 Rest of South & Central America Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the Blood Plasma Derivatives Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Grifols SA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Octapharma AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Monobind Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Takeda Pharmaceutical Co Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 CSL Behring LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 LFB SA
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Kedrion SpA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. South & Central America Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. South & Central America Blood Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 3. South & Central America Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. South & Central America Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. Brazil Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. Brazil Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 7. Brazil Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. Brazil Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Argentina Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. Argentina Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 11. Argentina Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. Argentina Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Rest of South & Central America Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Rest of Middle East Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 15. Rest of South & Central America Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of South & Central America Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Recent Inorganic Growth Strategies in the Blood Plasma Derivatives Market
Table 18. Recent Organic Growth Strategies in the Blood Plasma Derivatives Market
Table 19. Glossary of Terms
Table 1. South & Central America Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. South & Central America Blood Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 3. South & Central America Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. South & Central America Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. Brazil Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. Brazil Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 7. Brazil Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. Brazil Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Argentina Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. Argentina Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 11. Argentina Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. Argentina Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Rest of South & Central America Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Rest of Middle East Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 15. Rest of South & Central America Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of South & Central America Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Recent Inorganic Growth Strategies in the Blood Plasma Derivatives Market
Table 18. Recent Organic Growth Strategies in the Blood Plasma Derivatives Market
Table 19. Glossary of Terms
LIST OF FIGURES
Figure 1. South & Central America Blood Plasma Derivatives Market Segmentation
Figure 2. South & Central America Blood Plasma Derivatives Market, by Country
Figure 3. South & Central America Blood Plasma Derivatives Market Overview
Figure 4. Immunoglobulin Segment Held Largest Share of Type Segment in South & Central America Blood Plasma Derivatives Market
Figure 5. Brazil is Expected to Show Remarkable Growth During Forecast Period
Figure 6. South & Central America: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. South & Central America Blood Plasma Derivatives Market: Impact Analysis of Drivers and Restraints
Figure 9. South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. South & Central America Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)
Figure 11. Albumin: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Factor VIII: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Factor IX: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Immunoglobulin: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. IgG: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. IgM: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. IgA: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. IgD: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. IgE: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Hyperimmune Globulin: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. South & Central America Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)
Figure 23. Hemophilia: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Hypogammaglobulinemia: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Immunodeficiency Diseases: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Von Willebrand Disease: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other Applications: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. South & Central America Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)
Figure 29. Hospitals: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Clinics: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Other End Users: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. South & Central America: Blood Plasma Derivatives Market, by Key Country – Revenue (2021) (US$ Million)
Figure 33. South & Central America: Blood Plasma Derivatives Market, by country, 2021 & 2028 (%)
Figure 34. Brazil: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Argentina: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Rest of South & Central America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Growth Strategies in the Blood Plasma Derivatives Market
Figure 1. South & Central America Blood Plasma Derivatives Market Segmentation
Figure 2. South & Central America Blood Plasma Derivatives Market, by Country
Figure 3. South & Central America Blood Plasma Derivatives Market Overview
Figure 4. Immunoglobulin Segment Held Largest Share of Type Segment in South & Central America Blood Plasma Derivatives Market
Figure 5. Brazil is Expected to Show Remarkable Growth During Forecast Period
Figure 6. South & Central America: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. South & Central America Blood Plasma Derivatives Market: Impact Analysis of Drivers and Restraints
Figure 9. South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. South & Central America Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)
Figure 11. Albumin: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Factor VIII: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Factor IX: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Immunoglobulin: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. IgG: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. IgM: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. IgA: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. IgD: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. IgE: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Hyperimmune Globulin: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. South & Central America Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)
Figure 23. Hemophilia: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Hypogammaglobulinemia: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Immunodeficiency Diseases: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Von Willebrand Disease: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other Applications: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. South & Central America Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)
Figure 29. Hospitals: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Clinics: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Other End Users: South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. South & Central America: Blood Plasma Derivatives Market, by Key Country – Revenue (2021) (US$ Million)
Figure 33. South & Central America: Blood Plasma Derivatives Market, by country, 2021 & 2028 (%)
Figure 34. Brazil: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Argentina: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Rest of South & Central America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Growth Strategies in the Blood Plasma Derivatives Market
